"Cytochrome P450 Family 4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cytochrome P450 enzyme family that includes members which function in the metabolism of FATTY ACIDS, especially ARACHIDONIC ACIDS and their derivatives.
| Descriptor ID |
D000072470
|
| MeSH Number(s) |
D08.244.453.870 D08.811.682.690.708.170.496 D12.776.422.220.453.870
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P450 Family 4".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P450 Family 4".
This graph shows the total number of publications written about "Cytochrome P450 Family 4" by people in this website by year, and whether "Cytochrome P450 Family 4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytochrome P450 Family 4" by people in Profiles.
-
?-Hydroxylation of a-tocopheryl quinone reveals a dual function for cytochrome P450-4F2 in vitamin E metabolism. Bioorg Med Chem. 2018 11 01; 26(20):5555-5565.
-
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2018 09; 84(9):1868-1882.
-
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial. Eur J Clin Pharmacol. 2018 May; 74(5):571-582.
-
Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis. Drug Metab Pers Ther. 2017 12 20; 32(4):183-190.
-
A multiplex assay to detect variations in the CYP2C9, VKORC1, CYP4F2 and APOE genes involved in acenocoumarol metabolism. Clin Biochem. 2013 Jan; 46(1-2):167-9.
-
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient. Pharmacogenet Genomics. 2011 Jun; 21(6):344-6.
-
Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics. 2010 Mar; 20(3):187-94.